Brief: Collegium Pharmaceutical Q1 Revenue USD 144.9 Million Vs. IBES Estimate USD 146.9 Million
09/05/2024 21:02
May 09 (Reuters) - Collegium Pharmaceutical Q1 adjusted EBITDA USD 92.4 million vs. IBES estimate USD 94.3 million. * Q1 net income USD 27.7 million
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%